BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2540312)

  • 1. Cholestatic effect of carmustine in rats.
    Hoyt D; Larson RE
    J Pharmacol Exp Ther; 1989 Apr; 249(1):165-71. PubMed ID: 2540312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temporal relationship of changes in hepatobiliary function and morphology in rats following alpha-naphthylisothiocyanate (ANIT) administration.
    Kossor DC; Meunier PC; Handler JA; Sozio RS; Goldstein RS
    Toxicol Appl Pharmacol; 1993 Mar; 119(1):108-14. PubMed ID: 8470113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of 1,3-bis-(2-chloroethyl)-1-nitrosourea on cholephilic dye metabolism and excretion in anesthetized rats.
    Hoyt D; Larson RE
    J Pharmacol Exp Ther; 1989 May; 249(2):450-5. PubMed ID: 2724133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement of estradiol 17 beta-D-glucuronide cholestasis by intravenous administration of dimethylethanolamine in the rat.
    Alvaro D; Angelico M; Cantafora A; Gaudio E; Gandin C; Santini MT; Masella R; Capocaccia L
    Hepatology; 1991 Jun; 13(6):1158-72. PubMed ID: 1646761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of intrahepatic cholestasis by alpha-naphthylisothiocyanate in rats.
    Krell H; Höke H; Pfaff E
    Gastroenterology; 1982 Mar; 82(3):507-14. PubMed ID: 7054045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of complete biliary obstruction on bile secretion. Studies on the mechanisms of postcholestatic choleresis in the rat.
    Accatino L; Contreras A; Berdichevsky E; Quintana C
    J Lab Clin Med; 1981 Apr; 97(4):525-34. PubMed ID: 6259265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired activity of the bile canalicular organic anion transporter (Mrp2/cmoat) is not the main cause of ethinylestradiol-induced cholestasis in the rat.
    Koopen NR; Wolters H; Havinga R; Vonk RJ; Jansen PL; Müller M; Kuipers F
    Hepatology; 1998 Feb; 27(2):537-45. PubMed ID: 9462655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Furosemide choleresis in isolated perfused rat liver: partial dependency on perfusate sodium and chloride.
    Anwer MS
    J Pharmacol Exp Ther; 1985 Nov; 235(2):313-8. PubMed ID: 2997429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of diosgenin, a plant-derived steroid, on bile secretion and hepatocellular cholestasis induced by estrogens in the rat.
    Accatino L; Pizarro M; Solís N; Koenig CS
    Hepatology; 1998 Jul; 28(1):129-40. PubMed ID: 9657105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased paracellular permeability in intrahepatic cholestasis induced by carmustine (BCNU) in rats.
    Krell H; Fromm H; Larson RE
    Gastroenterology; 1991 Jul; 101(1):180-8. PubMed ID: 2044907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversible cholestasis induced by bromosulfophthalein in rabbits with enterohepatic circulation of bile acids maintained.
    Jiménez R; Larrubia O; Monte MJ; Gonzalez J; Esteller A
    Biomed Biochim Acta; 1988; 47(2):141-7. PubMed ID: 2845961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No increase of biliary permeability in ethinylestradiol-treated rats.
    Jaeschke H; Krell H; Pfaff E
    Gastroenterology; 1983 Oct; 85(4):808-14. PubMed ID: 6884706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytoprotective effects of trimetazidine in carmustine cholestasis.
    Girgin F; Tüzün S; Demir A; Kuralay F; Ozutemiz O; Tanyalcin T
    Exp Toxicol Pathol; 1999 Jul; 51(4-5):326-9. PubMed ID: 10445391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired biliary excretion of taurocholate associated with increased biliary tree permeability in mirex- or chlordecone-pretreated rats.
    Curtis LR; Hoyt D
    J Pharmacol Exp Ther; 1984 Dec; 231(3):495-501. PubMed ID: 6209385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatotoxicity of an HIV protease inhibitor in dogs and rats.
    Grossman SJ; Reinford N; Anderson C; Eydelloth RS; Alberts DW; Smith PF; Patrick DH
    Toxicol Appl Pharmacol; 1997 Sep; 146(1):40-52. PubMed ID: 9299595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MDR1 substrates/modulators protect against beta-estradiol-17beta-D-glucuronide cholestasis in rat liver.
    Liu Y; Huang L; Hoffman T; Gosland M; Vore M
    Cancer Res; 1996 Nov; 56(21):4992-7. PubMed ID: 8895755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. S-adenosyl-L-methionine protects the liver against the cholestatic, cytotoxic, and vasoactive effects of leukotriene D4: a study with isolated and perfused rat liver.
    Cincu RN; Rodríguez-Ortigosa CM; Vesperinas I; Quiroga J; Prieto J
    Hepatology; 1997 Aug; 26(2):330-5. PubMed ID: 9252142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of acute administration of high doses of ethanol on the canalicular Na+K+ dependent ATPASE in the isolated and perfused rat liver].
    Bellobuono A; Bellati G; Tempini S; Vitali L; Ideo G
    Boll Soc Ital Biol Sper; 1980 Sep; 56(18):1833-6. PubMed ID: 6263296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal of ethinylestradiol-induced cholestasis by epomediol in rat. The role of liver plasma-membrane fluidity.
    Miccio M; Orzes N; Lunazzi GC; Gazzin B; Corsi R; Tiribelli C
    Biochem Pharmacol; 1989 Oct; 38(20):3559-63. PubMed ID: 2554925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of liver plasma membrane fluidity in the pathogenesis of estrogen-induced cholestasis.
    Smith DJ; Gordon ER
    J Lab Clin Med; 1988 Dec; 112(6):679-85. PubMed ID: 3193023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.